Also trades as: 1177.HK (HKSE) · $vol 68M · SBMFF (OTC) · $vol 0M

$16.28

+1.78 (+12.28%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 64 · $14.5B mcap · 438M float · 0.0000% daily turnover · Short 74% of daily vol

Revenue

$31.0B +7.3% ▲

5Y CAGR: +5.5%

Gross Profit

$25.4B +8.0% ▲

5Y CAGR: +6.6%

Operating Income

$6.6B +8.0% ▲

5Y CAGR: +9.6%

Net Income

$2.3B -34.9% ▼

5Y CAGR: -3.8%

EPS (Diluted)

$2.60 -31.6% ▼

5Y CAGR: -2.8%

EBITDA

$7.8B +27.3% ▲

5Y CAGR: +6.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$26.9B	$26.0B	$26.2B	$28.9B	$31.0B
YoY Growth	+13.6%	-3.1%	+0.7%	+10.2%	+7.3%
Cost of Revenue	$5.3B	$5.8B	$5.0B	$5.3B	$5.6B
Gross Profit	$21.5B	$21.5B	$21.2B	$23.5B	$25.4B
Gross Margin	80.1%	82.8%	81.0%	81.5%	82.1%
R&D Expenses	$3.7B	$4.3B	$4.5B	$5.2B	$5.7B
SG&A Expenses	$12.7B	$12.6B	$11.1B	$12.2B	$13.1B
Operating Expenses	$17.2B	$16.0B	$15.5B	$17.4B	$18.8B
Operating Income	$5.1B	$5.6B	$5.8B	$6.1B	$6.6B
Operating Margin	18.9%	21.5%	22.1%	21.3%	21.4%
Interest Expense	$309M	$429M	$495M	$295M	$271M
Income Before Tax	$18.6B	$5.2B	$5.4B	$5.3B	$6.8B
Tax Expense	$2.0B	$697M	$797M	$493M	$1.6B
Net Income	$14.6B	$2.5B	$2.3B	$3.5B	$2.3B
Net Margin	54.4%	9.8%	8.9%	12.1%	7.4%
EPS (Diluted)	$14.60	$2.40	$1.99	$3.80	$2.60
EBITDA	$19.9B	$6.7B	$7.0B	$6.1B	$7.8B
Shares Outstanding	964M	951M	926M	915M	903M

Line Item	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2026 Q1	FY2026 Q2
Revenue	$7.9B	$7.9B	$6.5B	$6.5B	$8.8B	$8.8B	$9.7B	$9.7B
Cost of Revenue	$1.4B	$1.4B	$1.2B	$1.2B	$1.5B	$1.5B	$1.6B	$1.6B
Gross Profit	$6.5B	$6.5B	$5.3B	$5.3B	$7.2B	$7.2B	$8.1B	$8.1B
Gross Margin	82.1%	82.1%	80.8%	80.8%	82.5%	82.5%	83.0%	83.0%
R&D Expenses	$1.3B	$1.3B	$1.3B	$1.3B	$1.6B	$1.6B	$1.5B	$1.5B
SG&A Expenses	$3.4B	$3.4B	$2.7B	$2.7B	$3.8B	$3.8B	$3.1B	$3.1B
Operating Expenses	$4.7B	$4.7B	$3.9B	$3.9B	$5.4B	$5.4B	$4.7B	$4.7B
Operating Income	$1.8B	$1.8B	$1.2B	$1.2B	$1.9B	$1.9B	$3.4B	$3.4B
Operating Margin	22.7%	22.7%	18.4%	18.4%	21.4%	21.4%	35.2%	35.2%
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$1.8B	$1.8B	$832M	$832M	$3.0B	$3.0B	$3.7B	$3.7B
Tax Expense	$307M	$307M	-$182M	-$182M	$491M	$491M	$598M	$598M
Net Income	$1.5B	$1.5B	$241M	$241M	$1.7B	$1.7B	$1.7B	$1.7B
Net Margin	19.0%	19.0%	3.7%	3.7%	19.3%	19.3%	17.7%	17.7%
EPS (Diluted)	$0.77	$0.77	$0.28	$0.28	$1.88	$1.88	$1.90	$1.90
EBITDA	$2.0B	$2.0B	$1.1B	$1.1B	$2.0B	$2.0B	$3.5B	$3.5B
Shares Outstanding	923M	920M	909M	909M	901M	901M	902M	902M

SBHMY OTC